Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata significantly lowers the quality of life, especially in emotional and mental health aspects.

No single treatment is consistently effective for alopecia areata, and more research is needed.

A 300 mg monthly pulse of prednisolone effectively and safely treats widespread alopecia areata.

The new clobetasol propionate foam is effective and safe for treating alopecia areata.

Alopecia areata is a genetic and immune-related hair loss condition that is often associated with other autoimmune diseases and does not typically cause permanent damage to hair follicles.

Alopecia areata is a type of hair loss that can lead to complete baldness, often associated with other autoimmune conditions, and half of the cases may see hair return within a year.

Alopecia areata is caused by immune system attacks on hair follicles, often triggered by viral infections.

Alopecia areata patients often have low vitamin D levels, suggesting they might benefit from vitamin D supplements.

PUVA treatment is generally ineffective for alopecia areata.

Minoxidil helps hair growth in 63.6% of alopecia patients, with 27.3% having excellent results.

Restoring hair bulb immune privilege is crucial for managing alopecia areata.

PAD is common but often missed, needing lifestyle changes and medication for better outcomes.

Minoxidil solution helps hair regrowth in alopecia areata, with 5% being more effective.

People with alopecia areata often have other health issues like skin diseases, metabolic syndrome, stomach infections, lupus, anemia, thyroid problems, mental health issues, vitamin D deficiency, and hearing and eye problems.

Triamcinolone acetonide injections help hair regrow quickly in mild alopecia but not in severe cases.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

imTA and pulse therapy are effective for alopecia areata with manageable side effects, but relapse rates need improvement.

Alopecia areata treatment varies, with no optimal method established yet.

People with alopecia areata, a skin disease, generally have a poor quality of life, especially if more of their scalp is affected.

The unit area trichogram is a reliable method to assess hair loss and treatment response in people with androgenic alopecia by measuring hair density and thickness.

Alopecia areata is likely caused by a combination of genetic factors and immune system dysfunction, and may represent different diseases with various causes.

Trichoscopy helps diagnose and monitor alopecia areata by looking at a combination of specific hair and scalp features.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

How bad a woman's hair loss is doesn't always match how it affects her happiness and daily life.

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.

Most children treated with diphencyprone regrew some or all of their hair.

Topical JAK inhibitors may help children with alopecia areata regrow hair.

Animal models have helped understand hair loss from alopecia areata and find new treatments.

The Lexington LaserComb helped regrow hair in mice with a condition similar to human hair loss.

Minoxidil helps hair regrowth in alopecia patients, with 16 having good results and no side effects.